BioVenic

Animal Blood-Brain Barrier In Vitro Model Development

BioVenic develops species-aware animal blood-brain barrier in vitro models for veterinary neuropharmacology, neuroinfection, and comparative medicine. Customized endothelial, pericyte, and astrocyte co-cultures support permeability testing, TEER-ready barrier assessment, inflammatory challenge, transporter studies, and quantitative imaging.

Species-Aware Neurovascular Modeling

Build an Animal BBB Model Around the Transport or Barrier Question

Blood-brain barrier behavior depends on endothelial phenotype, supporting neurovascular cells, culture conditions, and species-specific transporter biology. A generic monolayer may be adequate for an early permeability question but insufficient for studies of inflammatory disruption, neuroinfection, or cell-cell signaling.

BioVenic develops customized animal BBB assays for veterinary school laboratories, animal disease researchers, comparative medicine scientists, preclinical pharmacology teams, and NAM developers. We align cell composition, barrier qualification, challenge conditions, and endpoints with the intended decision so the model is designed for a defined research use rather than assembled as a one-size-fits-all system.

Animal Blood-Brain Barrier Model Architecture

Model complexity should match the scientific question. BioVenic can develop endothelial-only systems for focused transport studies or add astrocytes and pericytes when neurovascular signaling and barrier phenotype require a multicellular context.

Key design inputs

Animal species, cell source, test article, expected exposure route, desired barrier stringency, inflammatory context, sampling schedule, and required imaging or molecular endpoints.

01

Endothelial Monoculture

A focused format for primary barrier formation, paracellular permeability, transporter-oriented screening, and early assay feasibility when supporting-cell interactions are not the main question.

02

Endothelial-Astrocyte Co-Culture

Adds astrocyte-derived cues to support neurovascular communication and can be useful when barrier integrity, inflammatory response, or disease-associated signaling is central to the study.

03

Endothelial-Pericyte-Astrocyte Tri-Culture

A higher-context model for studies requiring multiple neurovascular-unit cell types, including inflammatory disruption, comparative pathology, and complex barrier-response experiments.

Choosing a BBB Format for the Research Decision

Final design is customized to cell availability, species biology, and endpoint requirements.

Model Format Best-Fit Research Use Typical Barrier Readouts Added Biological Context
Endothelial monoculture Permeability screening and transporter-focused feasibility TEER-ready assessment, tracer permeability, junction markers Lowest complexity; endothelial-centric interpretation
Endothelial + astrocyte Barrier maturation, inflammatory signaling, neurovascular interaction Permeability, TEER, cytokines, tight-junction imaging Astrocyte-derived regulatory cues
Endothelial + pericyte + astrocyte Multicellular barrier response and disease-relevant disruption studies Integrated electrical, permeability, imaging, and inflammatory endpoints Broader neurovascular-unit interactions

Animal BBB In Vitro Model Development Service Scope

From cell preparation through assay-ready qualification, BioVenic integrates the model-building steps needed for a reproducible veterinary BBB assay.

Cell System

Cell Sourcing, Isolation, and Culture Optimization

Projects can begin from available animal brain vascular cells or project-specific primary-cell workflows. Culture conditions are optimized around cell attachment, viability, confluence, phenotype, and compatibility with the selected barrier format.

  • ✓Brain microvascular endothelial cell preparation or project-specified sourcing
  • ✓Astrocyte and pericyte integration based on study design
  • ✓Coating, medium, density, and culture-window optimization
Barrier Assembly

Transwell and Co-Culture Configuration

We configure the cellular arrangement, seeding sequence, membrane conditions, compartment orientation, and maturation window to support access to apical and basolateral compartments for controlled exposure and sampling.

  • ✓Endothelial-only, two-cell, or three-cell architecture
  • ✓Species-matched or hypothesis-driven supporting-cell selection
  • ✓Sampling plans aligned with permeability and inflammatory endpoints
Model Qualification

Barrier Integrity and Phenotype Confirmation

Barrier quality is assessed with project-appropriate electrical, permeability, molecular, and imaging endpoints. Qualification criteria are defined before testing so that experimental samples are interpreted against a documented barrier state.

  • ✓TEER or TEER-ready endpoint planning
  • ✓Paracellular tracer permeability and apparent permeability analysis
  • ✓ZO-1, occludin, claudin-5, or project-specific marker imaging
Experimental Challenge

Inflammatory Disruption and Test-Article Evaluation

The qualified model can be adapted to measure barrier changes after inflammatory or disease-relevant stimulation, or after exposure to candidate drugs and research reagents. Challenge conditions are selected to fit the mechanism and biosafety scope of the project.

  • ✓Inflammatory cytokine or pathway-targeted challenge design
  • ✓Barrier recovery, protection, or disruption comparisons
  • ✓Imaging and soluble-marker analysis for mechanistic context
Assay Integration

BBB Permeability, TEER, Inflammation, and Imaging Readouts

Endpoints can be combined into a single study plan so barrier function, molecular response, and morphology are interpreted together rather than as disconnected measurements.

Readout What It Addresses Example Output
TEER / electrical resistance Barrier tightness before, during, or after exposure Time-course or endpoint resistance data
Paracellular permeability Leakage across the endothelial barrier Flux and apparent permeability values
Compound transport Brain-facing transport potential and directional movement Apical-to-basolateral transport comparison
Tight-junction imaging Junction organization and barrier phenotype Fluorescence images and signal quantification
Inflammatory markers Barrier-associated inflammatory response Cytokine or marker expression changes
Cell morphology and viability Model health and exposure-related cellular effects Image sets, viability metrics, morphology notes

Need a veterinary BBB assay for a specific species or neuroinflammatory question?

Share the species, cell source, test article, and desired decision endpoint. BioVenic can define a feasibility-first model plan.

Workflow for Custom Animal BBB Model Development

A staged workflow separates model feasibility from experimental testing and creates clear decision points before larger studies begin.

1

Study Definition

Species, biology, format, test article, endpoints

2

Cell Preparation

Isolation or sourcing, expansion, prequalification

3

Barrier Assembly

Seeding, co-culture setup, maturation

4

Qualification

TEER, permeability, junction markers, imaging

5

Challenge & Testing

Compound, inflammatory, or mechanism-focused exposure

6

Data Package

Raw data, QC context, images, summary outputs

Neuropharmacology

Compare transport, barrier effects, or candidate exposure across species-relevant BBB conditions.

Neuroinfection & Inflammation

Measure barrier disruption, junction changes, and inflammatory responses under defined challenge conditions.

Comparative Medicine & NAMs

Build an animal BBB model that supports species-aware mechanistic comparisons and reduction-focused preclinical planning.

Published Data Supporting Species-Aware Blood-Brain Barrier Models

The figure compares barrier integrity in a primary porcine BBB system using cerebral endothelial cells alone or in triple coculture with porcine pericytes and astrocytes. The triple coculture produced higher TEER and lower sodium fluorescein permeability than the endothelial monoculture, demonstrating how supporting neurovascular cells and their arrangement can materially change the functional barrier phenotype.1

This study is directly relevant to species-aware veterinary BBB model development because the endothelial cells, pericytes, and astrocytes were isolated from the same animal species and evaluated through both electrical resistance and permeation measurements. BioVenic follows the same model-development logic by matching cell composition, coculture configuration, TEER-ready qualification, permeability assays, inflammatory markers, and imaging endpoints to the species and research decision.1

Porcine blood-brain barrier triple coculture compared with endothelial monoculture by TEER and permeability. (OA Literature)
Fig.1 Comparison of TEER and sodium fluorescein permeability for porcine endothelial monoculture and triple coculture BBB models. 1,2

Why Choose BioVenic for Animal BBB Model Development

Focused model design helps each readout answer a defined veterinary or comparative research question.

Species-Aware Design

Species-matched model design aligned with veterinary and comparative research questions.

Integrated Readouts

Barrier, permeability, inflammatory, and imaging endpoints within one project plan.

Flexible Cell Context

Endothelial, astrocyte, and pericyte combinations selected for study goals.

Decision-Ready Reporting

Clear raw data, QC context, and summaries for research decisions.

Frequently Asked Questions About Animal BBB In Vitro Models

BioVenic evaluates species feasibility according to tissue or cell availability, expected endothelial phenotype, supporting-cell options, and the intended assay. Companion-animal, livestock, and other comparative species can be considered. The final format is selected after reviewing the biological question and sample source rather than assuming one protocol transfers unchanged across species.

References

  1. Ledwig, Verena, and Stephan Reichl. "Isolation and Cultivation of Porcine Endothelial Cells, Pericytes and Astrocytes to Develop an In Vitro Blood-Brain Barrier Model for Drug Permeation Testing." Pharmaceutics 15.6 (2023): 1688. https://doi.org/10.3390/pharmaceutics15061688
  2. Distributed under Open Access license CC BY 4.0, without modification.
Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inquiry Basket